Article Text
PDFCommentary
Devaluation of persons by biotechnology-facilitated practices at the beginning and at the end of life
Statistics from Altmetric.com
Footnotes
Contributors BH is the only author of this commentary.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Expressivism at the beginning and end of life
- Commentary on ‘expressivism at the beginning and end of life’
- Response to commentaries on ‘Expressivism at the beginning and end of life’
- Reed on expressivism at the end of life: a bridge too far
- Expressivism at the beginning and end of life
- Hostile environments? Down’s syndrome and genetic screening in contemporary culture
- An autonomy-based approach to assisted suicide: a way to avoid the expressivist objection against assisted dying laws
- The case for physician assisted suicide: how can it possibly be proven?
- The case for physician assisted suicide: not (yet) proven
- Prenatal diagnosis and selective abortion: a result of the cultural turn?